(HealthDay)—The first human clinical trial of a nasal vaccine to slow the progression of Alzheimer's disease is set to begin after nearly 20 years of research.
Nov 17, 2021
0
84
The first three coronavirus vaccines earned Emergency Use Authorization more than a year ago. To date, no other vaccines have been put into use in the U.S—but that will soon change. More than 40 vaccines are undergoing ...
May 5, 2022
0
119
A clinical trial testing a freeze-dried, temperature-stable experimental tuberculosis (TB) vaccine in healthy adults found that it was safe and stimulated both antibodies and responses from the cellular arm of the immune ...
Mar 6, 2023
0
98
A new study led by scientists at the Walter Reed Army Institute of Research has shown for the first time that a single dose of an experimental Zika vaccine in a dengue-experienced individual can boost pre-existing flavivirus ...
Feb 3, 2020
0
199
University of Miami Miller School of Medicine researchers led a unique and groundbreaking randomized controlled trial showing umbilical cord derived mesenchymal stem cell infusions safely reduce risk of death and quicken ...
Jan 5, 2021
0
91
Using a novel form of immune-genetic therapy, researchers from Yale School of Medicine and the Jagiellonian University College of Medicine in Poland have successfully inhibited a strong immune allergic inflammatory response ...
Jul 10, 2013
0
0
Dozens of companies, from biotech start-ups to Big Pharma, are racing to develop a safe and effective COVID-19 vaccine, because the world needs it and for the potential pay day.
Oct 16, 2020
0
29
Antidepressants lead to a small, but clinically unimportant, improvement in pain and function in patients with osteoarthritis, according to a review published online Oct. 21 in the Cochrane Library.
Nov 29, 2022
0
24
Patients living with fibromyalgia (FM)—a disease that predominantly affects women and is characterized by chronic pain, fatigue and brain fog—often find limited treatment options and a scarcity of explanations for their ...
Sep 20, 2023
0
39
When clinical trials were conducted to determine the immunogenicity—the ability to elicit an immune response—for the first two vaccines marshaled against SARS-CoV-2the virus that causes COVID-19, one group was not among ...
Mar 25, 2021
0
35
